Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study

被引：0
|
作者：
Nazha, Bassel
Brown, Jacqueline T.
Liu, Yuan
Kissick, Haydn
Carthon, Bradley Curtis
Kucuk, Omer
Harik, Lara R.
Narayan, Vikram M.
Joshi, Shreyas S.
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
[3] Emory Univ, Dept Urol, Sch Med, Atlanta, GA USA
[4] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA USA
[5] Emory Univ, Dept Urol, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4615
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results
    Funt, Samuel A.
    Grivas, Petros
    Gao, Xin
    Vaena, Daniel A.
    Zhang, Tian
    Milowsky, Matthew I.
    Rao, Mayank
    Liu, Harry
    Tipton, Kimberly
    An, Grace
    Jin, Feng
    Forgie, Alison J.
    Randolph, Sophia
    Tsiatis, Athanasios C.
    Jain, Rohit K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] KEYNOTE-905/EV-303: A phase 3 study to evaluate the efficacy and safety of perioperative pembrolizumab or pembrolizumab plus enfortumab vedotin (EV) for muscle-invasive bladder cancer (MIBC).
    Necchi, Andrea
    Bedke, Jens
    Galsky, Matt D.
    Shore, Neal D.
    Xylinas, Evanguelos
    Jia, Calvin
    Dubrovsky, Leonid
    Moreno, Blanca Homet
    Witjes, J. Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Phase I/II study of docetaxel plus FOLFOX in locally advanced or metastatic gastric cancer patients
    Filippelli, G.
    Lucia, M.
    La Gattuta, G.
    Caputo, A.
    Olivito, V
    Talarico, R.
    De Simone, R.
    Dima, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 28
  • [44] ARE STANDARD INDIRECT TREATMENT COMPARISON METHODS SUITABLE TO COMPARE FIRST-LINE VS MAINTENANCE THERAPIES? AN ASSESSMENT OF ENFORTUMAB VEDOTIN plus PEMBROLIZUMAB VS AVELUMAB IN LOCALLY ADVANCED/METASTATIC UROTHELIAL CARCINOMA
    Dillon, R.
    Wilson, F.
    Chan, K.
    McLoone, D.
    Kodi, E.
    Pepper, A. N.
    Shih, V
    Keeping, S.
    VALUE IN HEALTH, 2024, 27 (06) : S42 - S42
  • [45] Enfortumab vedotin and pembrolizumab. Management of side effects during first line combined treatment for advanced or metastatic urothelial carcinoma
    Retz, Margitta
    Grimm, Marc-Oliver
    Leucht, Katharina
    Zschaebitz, Stefanie
    UROLOGIE, 2025, 64 (01): : 60 - 74
  • [46] Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
    Swiecicki, Paul L.
    Yilmaz, Emrullah
    Rosenberg, Ari Joseph
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Zhao, Yongyun
    Mihm, Michael
    Kaplan, Jason
    Gorla, Seema
    Geiger, Jessica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [47] A phase II multicenter study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors (E-VIRTUE)
    Chandran, Elias
    Simon, Nicholas I.
    Girardi, Daniel Da Motta
    Ley, Lisa
    Wang, Tzu-Fang
    Kydd, Andre Rashad
    Atiq, Saad Omar
    Boudjadi, Salah
    Stukes, Ian
    Smith, Elizabeth
    Akbulut, Dilara
    Niglio, Scot Anthony
    Gurram, Sandeep
    Bilusic, Marijo
    Steinberg, Seth M.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer
    Bendell, Johanna
    Saleh, Mansoor
    Rose, April A. N.
    Siegel, Peter M.
    Hart, Lowell
    Sirpal, Surendra
    Jones, Suzanne
    Green, Jennifer
    Crowley, Elizabeth
    Simantov, Ronit
    Keler, Tibor
    Davis, Thomas
    Vahdat, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) : 3619 - +
  • [49] A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer.
    Duska, Linda R.
    Showalter, Timothy Norman
    Petroni, Gina R.
    Bullock, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival.
    Cen, Putao
    Chan, Kok Hoe
    Canfield, Steven
    Shu, Tung
    Maithel, Neha
    Tammisetti, Varaha
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345